Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study

• Bruno Fattizzo,
• Marc Michel,
• Anna Zaninoni,
• Juri Giannotta,
• Stephanie Guillet,
• Henrik Frederiksen,
• Josephine M.I. Vos,
• Francesca R. Mauro,
• Bernd Jilma,
• Andrea Patriarca,
• Francesco Zaja,
• Anita Hill,
• Sigbiørn Berentsen,
• Wilma Barcellini

Affiliations

Bruno Fattizzo

Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano and University of Milan, Milan, Italy;

Marc Michel

Department of Internal Medecine, Henri Mondor University Hospital, Assistance Pub Hôpitaux de Paris,Creteil, France;

Anna Zaninoni

Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano and University of Milan, Milan, Italy;

Juri Giannotta

Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano and University of Milan, Milan, Italy;

Stephanie Guillet

Department of Internal Medecine, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Creteil, France;

Henrik Frederiksen

Department of Haematology, Odense University Hospital, Denmark;

Josephine M.I. Vos

Amsterdam UMC, location AMC, Department of Hematology, Amsterdam, The Netherlands;

Francesca R. Mauro

Haematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy;

Bernd Jilma

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria;

Andrea Patriarca

UO Ematologia, AOU Maggiore della Carità, Novara, Italy;

Francesco Zaja

S.C. Ematologia, Azienda Sanitaria Universitaria Integrata, Trieste, ITA;

Anita Hill

Haematology, Leeds Teaching Hospitals, Leeds, United Kingdom;

Sigbiørn Berentsen

Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway

Wilma Barcellini

Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano and University of Milan, Milan, Italy;